News

AddToAny

Google+ Facebook Twitter Twitter

Diagnosing children’s cancer in the pandemic

A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic.

The research, which was presented at the National Cancer Research Institute Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.

These findings suggest COVID-19 has had a detrimental effect on early diagnosis of cancer in children and young people.

The study was presented by Dr Defne Saatci from the University of Oxford.

She said: “Spotting cancer early and starting treatment promptly gives children and young people the best chance of surviving. We already know that the COVID-19 pandemic led to worrying delays in diagnosis and treatment for many adults with cancer, so we wanted to understand how the pandemic affected children’s cancer services.”

During the first wave, the researchers found that 380 patients were diagnosed with a brain tumour, lymphoma, leukaemia, sarcoma or renal tumour.

This is approximately 17% lower than in previous years.

They found that the average time between diagnosis and the start of treatment was slightly shorter during the first COVID-19 wave, but that children were more than twice as likely to be admitted to intensive care before their cancer was diagnosed.

bit.ly/3CgxOPx

Image credit | Shutterstock

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top